HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
N-palmitoyl dihydroglucocerebroside
used in the diagnosis of Gaucher Disease
Also Known As:
NPDGC
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Organic Chemicals: 133
Amides: 2428
Ceramides: 4082
Cerebrosides: 106
Glucosylceramides: 763
N-palmitoyl dihydroglucocerebroside: 1
Carbohydrates: 22023
Glycoconjugates: 1353
Glycolipids: 2799
Glycosphingolipids: 1659
Neutral Glycosphingolipids: 101
Ceramides: 4082
Cerebrosides: 106
Glucosylceramides: 763
N-palmitoyl dihydroglucocerebroside: 1
Lipids: 114793
Glycolipids: 2799
Glycosphingolipids: 1659
Neutral Glycosphingolipids: 101
Ceramides: 4082
Cerebrosides: 106
Glucosylceramides: 763
N-palmitoyl dihydroglucocerebroside: 1
Membrane Lipids: 1591
Sphingolipids: 3208
Glycosphingolipids: 1659
Neutral Glycosphingolipids: 101
Ceramides: 4082
Cerebrosides: 106
Glucosylceramides: 763
N-palmitoyl dihydroglucocerebroside: 1
Related Diseases
1.
Gaucher Disease (Gaucher's Disease)
08/01/1987 - "
Gaucher disease: accurate identification of asymptomatic French-Canadian carrier using nonlabeled authentic sphingolipid substrate N-palmitoyl dihydroglucocerebroside.
"
Related Drugs and Biologics
1.
Sphingolipids